The study examined the effectiveness of pharmacist-led telemedicine services on reducing adverse drug events (ADEs) from high-risk medications in nursing home residents by conducting thorough medication reviews upon admission and providing ongoing support.
Conducted in four nursing homes over one year, the quality improvement study used a stepped-wedge design to compare the new telemedicine approach against usual care, with 652 alerts documented for the 2,127 residents screened.
Results showed that the intervention significantly lowered the incidence of alert-specific ADEs by 92%, resulting in only 9 incidents in the intervention group compared to 31 in usual care, while hospitalization rates remained similar for both groups.